Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1Head & Neck 1

Conditions

Stomatitis 1Mucositis 1Head and Neck Neoplasms 1

Interventions

Low-Level Light Therapy 14Fibroblast Growth Factor 7 10Cisplatin 6Standard of Care 5avasopasem manganese 4Radiotherapy, Intensity-Modulated 4Propolis 4Mouthwashes 4Cryotherapy 4Water 3Sodium Bicarbonate 3Saline Solution 3Radiotherapy 3Laser Therapy 3Injections 3Drug Therapy 3Control Groups 3Benzydamine 3golotimod 2aluminum hydroxide, magnesium hydroxide, drug combination 2Xylitol 2Vitamin E 2Vitamin B 12 2Sodium Chloride 2Saliva, Artificial 2RRx-001 2Practice Guidelines as Topic 2Lidocaine 2Honey 2Glutamine 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Stomatitis × brilacidin × Clear all
NCT02324335 2019-01-16

Brilacidin

Innovation Pharmaceuticals, Inc.

Phase 2 Completed
61 enrolled 12 charts
Head & NeckOther

Head and Neck Neoplasms, Stomatitis, Mucositis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡